Search by Drug Name or NDC

    NDC 41250-0474-02 cold and sinus PE 325; 10; 100; 5 mg/1; mg/1; mg/1; mg/1 Details

    cold and sinus PE 325; 10; 100; 5 mg/1; mg/1; mg/1; mg/1

    cold and sinus PE is a ORAL TABLET, COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Meijer. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 41250-0474
    Product ID 41250-474_e95a2a65-9446-b5d9-e053-2995a90adb21
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name cold and sinus PE
    Proprietary Name Suffix n/a
    Non-Proprietary Name ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 325; 10; 100; 5
    Active Ingredient Units mg/1; mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Meijer
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through n/a

    Package

    NDC 41250-0474-02 (41250047402)

    NDC Package Code 41250-474-02
    Billing NDC 41250047402
    Package 2 BLISTER PACK in 1 CARTON (41250-474-02) / 12 TABLET, COATED in 1 BLISTER PACK
    Marketing Start Date 2017-04-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 81cc04b2-7f4e-531f-e053-2991aa0a2c17 Details

    Revised: 9/2022